Everybody is talking about peptides right now, BPC-157, CJC-1295, Ipamorelin, Tessamorelin, GLP-1 medications, Tirzepatide, Retatrutide, NAD, MOTS-c, SS-31, and longevity stacks. But here’s the problem: most people are starting peptide therapy without baseline labs, metabolic markers, cardiovascular risk testing, hormone panels, kidney function, liver markers, or any real data. They are relying on TikTok, influencers, symptoms, and “how they feel” instead of objective biomarkers.

In this episode, Dr. Ryan breaks down why peptides are not magic, why blind peptide use can backfire, and why you need blood work before starting GLP-1s, growth hormone secretagogues, healing peptides, or fat loss stacks. You’ll learn how fasting insulin, A1C, ApoB, hs-CRP, IGF-1, thyroid markers, kidney function, liver health, body composition, and inflammation markers help determine whether peptides are actually helping you or quietly making things worse. This is for anyone considering peptide therapy, using weight loss peptides, or trying to optimize health, longevity, fat loss, recovery, hormones, and performance without gambling with their body.

You’ll learn:

→ Why symptom tracking alone is not enough when using peptides

→ How GLP-1 weight loss can still lead to muscle loss or poor metabolic health

→ Why IGF-1 matters for growth hormone peptides like CJC-1295 and Ipamorelin

→ Which lab markers reveal inflammation, insulin resistance, liver stress, kidney stress, and cardiovascular risk before starting a peptide protocol.

Learn more about Dr. Ryan Hewitt by visiting the following links:

Dr. Ryan Hewitt Website: https://www.drryanhewitt.com/

The Weaponized Body Program: https://www.theweaponizedbody.com/

Weaponized wellness HRT: https://www.weaponizedwellness.com/

Instagram: https://www.instagram.com/theweaponizeddad/

YouTube: https://www.youtube.com/@theweaponizedbody

Learn more about your ad choices. Visit megaphone.fm/adchoices